Proteomics

Dataset Information

0

A Multi-Omics Interpretable Machine Learning Model Reveals Modes of Action of Small Molecules


ABSTRACT: Cells expressing mutant huntingtin were treated in triplicate with serum-free DMEM with vehicle (Q111SST) or serum-free DMEM with one of 4 protective compounds (Cyproheptadine, Loxapine, Diacylglycerol Kinase Inhibitor II, Meclizine) for 24 hours. Wild type cells were also treated with serum-free DMEM with vehicle (Q7SST) as an additional control for 24 hours. We examined the compounds' proteomic and some phosphoproteomic effects on the cells using shotgun proteomics.

INSTRUMENT(S): Orbitrap Fusion

ORGANISM(S): Mus Musculus (ncbitaxon:10090)

SUBMITTER: Ernest Fraenkel  

PROVIDER: MSV000084607 | MassIVE | Wed Nov 20 19:46:00 GMT 2019

REPOSITORIES: MassIVE

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1
altmetric image

Publications

A Multi-Omics Interpretable Machine Learning Model Reveals Modes of Action of Small Molecules.

Patel-Murray Natasha L NL   Adam Miriam M   Huynh Nhan N   Wassie Brook T BT   Milani Pamela P   Fraenkel Ernest E  

Scientific reports 20200122 1


High-throughput screening and gene signature analyses frequently identify lead therapeutic compounds with unknown modes of action (MoAs), and the resulting uncertainties can lead to the failure of clinical trials. We developed an approach for uncovering MoAs through an interpretable machine learning model of transcriptomics, epigenomics, metabolomics, and proteomics. Examining compounds with beneficial effects in models of Huntington's Disease, we found common MoAs for compounds with unrelated s  ...[more]

Similar Datasets

2019-05-24 | ST001186 | MetabolomicsWorkbench
2019-03-20 | MSV000083602 | MassIVE
2021-04-20 | PXD019331 | Pride
2012-07-05 | E-GEOD-39136 | biostudies-arrayexpress
2016-07-22 | GSE71717 | GEO
2010-05-31 | GSE15218 | GEO
2006-12-31 | GSE5073 | GEO
2009-08-13 | GSE17624 | GEO
2016-07-22 | E-GEOD-71717 | biostudies-arrayexpress
2004-02-28 | GSE981 | GEO